Featured on the List | Jiuzhitang Maker Receives National High-Tech Enterprise Certification Once Again
2022-11-18
Recently, Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. has once again been recognized as a National High-Tech Enterprise. , awarded the "National High-Tech Enterprise" honor certificate.

National High-Tech Enterprise It is jointly recognized by three departments: the Ministry of Science and Technology, the Ministry of Finance, and the State Administration of Taxation. The process involves a comprehensive, all-around evaluation of enterprises, with high qualification thresholds, stringent standards, and a lengthy timeline. Companies must undergo multiple rounds of screening, rigorous review, and public disclosure to qualify. It is one of the most prestigious honors for China's high-tech enterprises.
Jiuzhitang Maker Continuously being recognized as a "National High-Tech Enterprise" marks the company's Core Technology for Stem Cell Products , scientific research and innovation system, Technology commercialization capability, Independent intellectual property rights, company growth indicators, Stem cell drug development capabilities, In terms of organizational management capabilities, talent structure, and other aspects, Received full recognition and affirmation from the country's authoritative authorities. It also highlights Jiuzhitang Maker's robust corporate strength in the stem-cell drug R&D field, showcasing its world-class innovation drive, independent R&D capabilities, standardized management practices, and strong ability to commercialize scientific and technological achievements.
In the future, Jiuzhitang Maker will transition from Continuously strengthening efforts in platform development, technological innovation, research management, and talent cultivation. , fully leveraging the more efficient collaboration of global resources, accelerating the clinical launch of stem cell-based therapies, speeding up the translation of stem cell research into practical applications, effectively fostering deep integration among industry, academia, and research, continuously enhancing our company’s core competitiveness, and making a significant contribution to driving high-quality development of China’s stem cell industry.
Previous:
Related News